Efficacy and safety of combining anti-angiogenic therapy, radiotherapy, and PD-1 inhibitors in patients with driver gene-negative non-small cell lung cancer brain metastases: a retrospective study
Combining AT, RT, and PD-1 inhibitors can substantially improve iLPFS and iDPFS for patients with driver gene-negative NSCLC with BM; however, it is not significantly associated with better OS.
Authors
- Qian Sun (ORCID: https://orcid.org/0000-0002-4878-3599)
- Feng Cai (ORCID: https://orcid.org/0000-0003-4473-6477)
- Mingdan Zhao
- Hao Jiang (ORCID: https://orcid.org/0000-0001-7955-1363)
- Rujun Chen (ORCID: https://orcid.org/0000-0002-9451-6280)
- Xianwen Zhang (ORCID: https://orcid.org/0000-0001-5329-7571)
- Zhen Cui (ORCID: https://orcid.org/0000-0001-8723-1175)
Institutions
- Bengbu Medical College (CN)
- First Affiliated Hospital of Bengbu Medical College (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1186/s12885-024-13264-9
- Citations
- 4
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.68
Funders
- Bengbu Medical College